| Hematological findings and complications of COVID‐19 E Terpos, I Ntanasis‐Stathopoulos, I Elalamy, E Kastritis, TN Sergentanis, ... American journal of hematology 95 (7), 834-847, 2020 | 2430 | 2020 |
| International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer D Farge, P Debourdeau, M Beckers, C Baglin, RM Bauersachs, B Brenner, ... Journal of Thrombosis and Haemostasis 11 (1), 56-70, 2013 | 731 | 2013 |
| Vitamin K antagonists in heart disease: Current status and perspectives (Section III) R De Caterina, S Husted, L Wallentin, F Andreotti, H Arnesen, ... Thrombosis and haemostasis 110 (12), 1087-1107, 2013 | 561 | 2013 |
| Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines Z Zhai, C Li, Y Chen, G Gerotziafas, Z Zhang, J Wan, P Liu, I Elalamy, ... Thrombosis and haemostasis 120 (06), 937-948, 2020 | 460 | 2020 |
| International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer P Debourdeau, D Farge, M Beckers, C Baglin, RM Bauersachs, B Brenner, ... Journal of Thrombosis and Haemostasis 11 (1), 71-80, 2013 | 422 | 2013 |
| Prevention and treatment of venous thromboembolism International Consensus Statement (guidelines according to scientific evidence) AN Nicolaides, J Fareed, AK Kakkar, HK Breddin International angiology 25 (2), 101, 2006 | 397* | 2006 |
| Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline A Falanga, C Ay, M Di Nisio, G Gerotziafas, L Jara-Palomares, F Langer, ... Annals of Oncology 34 (5), 452-467, 2023 | 381 | 2023 |
| Prevention and treatment of venous thromboembolism--International Consensus Statement. AN Nicolaides, J Fareed, AK Kakkar, AJ Comerota, SZ Goldhaber, R Hull, ... International angiology: a journal of the International Union of Angiology …, 2013 | 323 | 2013 |
| A predictive score for thrombosis associated with breast, colorectal, lung, or ovarian cancer: the prospective COMPASS–Cancer‐Associated thrombosis study GT Gerotziafas, A Taher, H Abdel‐Razeq, E AboElnazar, AC Spyropoulos, ... The Oncologist 22 (10), 1222-1231, 2017 | 305 | 2017 |
| Disseminated intravascular coagulation: an update on pathogenesis, diagnosis, and therapeutic strategies C Papageorgiou, G Jourdi, E Adjambri, A Walborn, P Patel, J Fareed, ... Clinical and applied thrombosis/hemostasis 24 (9_suppl), 8S-28S, 2018 | 290 | 2018 |
| Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (fondaparinux) MM Samama, GT Gerotziafas Thrombosis research 109 (1), 1-11, 2003 | 218 | 2003 |
| Comparative pharmacokinetics of LMWHs MM Samama, GT Gerotziafas Seminars in thrombosis and hemostasis 26 (s1), 031-038, 2000 | 215 | 2000 |
| Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis V Dufrost, J Risse, T Reshetnyak, M Satybaldyeva, Y Du, XX Yan, S Salta, ... Autoimmunity reviews 17 (10), 1011-1021, 2018 | 213 | 2018 |
| Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19: position paper from VAS-European independent foundation in angiology … GT Gerotziafas, M Catalano, MP Colgan, Z Pecsvarady, JC Wautrecht, ... Thrombosis and haemostasis 120 (12), 1597-1628, 2020 | 210 | 2020 |
| In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban GT Gerotziafas, I Elalamy, F Depasse, E Perzborn, MM Samama Journal of Thrombosis and Haemostasis 5 (4), 886-888, 2007 | 206 | 2007 |
| Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram … GT Gerotziafas, F Depasse, J Busson, L Leflem, I Elalamy, MM Samama Thrombosis journal 3 (1), 16, 2005 | 190 | 2005 |
| In vitro aspirin resistance detected by PFA‐100TM closure time: pivotal role of plasma von Willebrand factor T Chakroun, G Gerotziafas, F Robert, C Lecrubier, MM Samama, M Hatmi, ... British journal of haematology 124 (1), 80-85, 2004 | 170 | 2004 |
| International consensus statement: guidelines according to scientific evidence AN Nicolaides, HK Breddin, P Carpentier, S Coccheri International angiology 24 (1), 1, 2005 | 160 | 2005 |
| Tinzaparin and enoxaparin given at prophylactic dose for eight days in medical elderly patients with impaired renal function I Mahé, M Aghassarian, L Drouet, K Lacut, JJ Heilmann, D Mottier, ... Thrombosis and haemostasis 97 (04), 581-586, 2007 | 156 | 2007 |
| Improved strategies to counter the COVID-19 pandemic: Lockdowns vs. primary and community healthcare K Farsalinos, K Poulas, D Kouretas, A Vantarakis, M Leotsinidis, ... Toxicology Reports 8, 1-9, 2021 | 151 | 2021 |
Ismail ELALAMYVerified email at aphp.fr
